Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Beneish M-Score: -3.38 (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603882 Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
74 GF Score
Price ¥26.71
GF Value ¥27.91
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Guangzhou Kingmed Diagnostics Group Co Beneish M-Score?

Guangzhou Kingmed Diagnostics Group Co SHSE:603882 +0.07% 74 Beneish M-Score is -3.38 as of Jul. 21, 2026. GuruFocus rates SHSE:603882 with a GF Score™ of 74/100 and a GF Value™ of ¥27.91 (Fairly Valued). The stock has 7 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Guangzhou Kingmed Diagnostics Group Co ranks better than 85.05% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.38 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Guangzhou Kingmed Diagnostics Group Co's Beneish M-Score or its related term are showing as below:

SHSE:603882' s Beneish M-Score Range Over the Past 10 Years
Min: -3.55   Med: -2.4   Max: 1.52
Current: -3.38

During the past 13 years, the highest Beneish M-Score of Guangzhou Kingmed Diagnostics Group Co was 1.52. The lowest was -3.55. And the median was -2.40.


Guangzhou Kingmed Diagnostics Group Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Guangzhou Kingmed Diagnostics Group Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Kingmed Diagnostics Group Co Beneish M-Score Chart

Guangzhou Kingmed Diagnostics Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.00 -1.73 -2.47 -3.14 -3.41

Guangzhou Kingmed Diagnostics Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.31 -3.53 -3.55 -3.41 -3.38

SHSE:603882 vs TMO, DHR, IDXX: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, Guangzhou Kingmed Diagnostics Group Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Kingmed Diagnostics Group Co Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangzhou Kingmed Diagnostics Group Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Guangzhou Kingmed Diagnostics Group Co's Beneish M-Score falls into.


SHSE:603882
74GF Score
Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Kingmed Diagnostics Group Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Guangzhou Kingmed Diagnostics Group Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9124+0.528 * 0.9518+0.404 * 1.0515+0.892 * 0.868+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1848+4.679 * -0.140603-0.327 * 1.029
=-3.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥3,535 Mil.
Revenue was 1350.978 + 1492.301 + 1541.222 + 1530.424 = ¥5,915 Mil.
Gross Profit was 471.435 + 514.822 + 563.263 + 529.376 = ¥2,079 Mil.
Total Current Assets was ¥6,187 Mil.
Total Assets was ¥9,200 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,931 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥566 Mil.
Total Current Liabilities was ¥1,978 Mil.
Long-Term Debt & Capital Lease Obligation was ¥703 Mil.
Net Income was 42.791 + -93.634 + 5.197 + -57.022 = ¥-103 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 43.43 + 530.101 + 321.438 + 295.965 = ¥1,191 Mil.
Total Receivables was ¥4,464 Mil.
Revenue was 1466.505 + 1570.692 + 1737.946 + 2039.645 = ¥6,815 Mil.
Gross Profit was 487.57 + 407.763 + 626.332 + 758.114 = ¥2,280 Mil.
Total Current Assets was ¥6,819 Mil.
Total Assets was ¥9,855 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,934 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥550 Mil.
Total Current Liabilities was ¥2,147 Mil.
Long-Term Debt & Capital Lease Obligation was ¥644 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3534.81 / 5914.925) / (4463.685 / 6814.788)
=0.597609 / 0.655
=0.9124

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2279.779 / 6814.788) / (2078.896 / 5914.925)
=0.334534 / 0.351466
=0.9518

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (6187.259 + 1930.999) / 9200.408) / (1 - (6818.528 + 1933.993) / 9854.91)
=0.11762 / 0.111862
=1.0515

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5914.925 / 6814.788
=0.868

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1933.993)) / (0 / (0 + 1930.999))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(565.644 / 5914.925) / (550.045 / 6814.788)
=0.09563 / 0.080713
=1.1848

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((703.297 + 1977.976) / 9200.408) / ((643.887 + 2147.223) / 9854.91)
=0.29143 / 0.28322
=1.029

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-102.668 - 0 - 1190.934) / 9200.408
=-0.140603

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Guangzhou Kingmed Diagnostics Group Co has a M-score of -3.38 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.38 mean?
Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) has a Beneish M-Score of -3.38 as of Jul. 21, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. According to the industry distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #29 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 14.9%.
Is Guangzhou Kingmed Diagnostics Group Co's Beneish M-Score too high?
Guangzhou Kingmed Diagnostics Group Co's current Beneish M-Score is -3.38. Based on the distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #29 out of 194 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Guangzhou Kingmed Diagnostics Group Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Kingmed Diagnostics Group Co's Beneish M-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #29 out of 194 companies for Beneish M-Score. This places Guangzhou Kingmed Diagnostics Group Co in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. Guangzhou Kingmed Diagnostics Group Co's current Beneish M-Score is -3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Kingmed Diagnostics Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) is currently considered Fairly Valued. The stock's GF Value™ is ¥27.91, compared to a current price of ¥26.71 — trading 4.3% below its estimated fair value. The current Beneish M-Score is -3.38. Guangzhou Kingmed Diagnostics Group Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Guangzhou Kingmed Diagnostics Group Co (SHSE:603882), the current Beneish M-Score is -3.38 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co stock appears to be undervalued. The current stock price of ¥26.71 is trading 4.3% below its estimated GF Value™ of ¥27.91. GuruFocus considers Guangzhou Kingmed Diagnostics Group Co to be Fairly Valued.

Key valuation signals for SHSE:603882:

  • Beneish M-Score: -3.38
  • GF Value™: ¥27.91 vs. price of ¥26.71 (4.3% below fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangzhou Kingmed Diagnostics Group Co Business Description

Address International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
74GF Score

Get the complete analysis for SHSE:603882

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.71
Price
¥27.91
GF Value